Bio: Sharon Barr is the Senior Vice President, Head of Research and Product Development at Alexion AstraZeneca. She is responsible for drug discovery, process development and clinical supply as well as clinical biomarkers and bioanalytical discovery, rare disease diagnostics and bioinformatics supporting the rare disease pipeline from target discovery through post-marketing. With more than 18 years industry experience she has previously led the translational research, precision medicine team and global development teams. Sharon received her PhD in molecular biology from New York University, and completed a postdoctoral fellowship focused on mechanisms of DNA Damage and Repair at Stanford University.

Find out more about Alexion AstraZeneca by visiting their website.